IgM Monoclonal Gammopathy of Undetermined Significance

IgM Monoclonal Gammopathy of Undetermined Significance — Trials · CancerIndex

Clinical trials

Registered studies

1 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05065554	ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy	active not recruiting	Phase 2	12	Shayna Sarosiek, MDOTHER	1	Dec 5, 2025	clinicaltrials

Data updated 23 days agoSource updated Dec 5, 2025source: clinicaltrials